Delivery Order SPE2DB22D9353-SPE2DB25FX1SS

Award Date 2/26/25
Potential Completion Date 3/19/25
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product, at a ceiling value of $15,761.76. The delivery order has a firm fixed price pricing structure and runs through June 11, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The firm fixed-price contract has a ceiling value of $40,443.20 and a performance period through August 30, 2024. The contract is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a pharmaceutical product. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $27,230.40 and covers the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a branded pharmaceutical product. The contract is a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,313.48, is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a prescription drug product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2024. It is not associated with a set-aside program. DMS Pharmaceutical Group Inc....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $54,432.80 fixed-price contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, with a performance period ending on November 25, 2022. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers a wide range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $81,476.40 contract is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized medication product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $12,567.70, is for the provision of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. The contract is a firm fixed-price delivery order, with a period of performance running through March 6, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply...
This firm fixed-price delivery order, valued at $40,443.20, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML to support the recurring pharmaceutical supply needs of military health facilities. This order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) under the SPE2DB24FYP08 contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $39,404.40, is for the delivery of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a branded pharmaceutical product. This is a firm fixed-price delivery order with a completion date of May 23, 2024. The contract does not have a set-aside designation. DMS...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,880.88 contract is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a specialized pharmaceutical product. The delivery order was issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which covers a wide range of branded and generic...
  • SPE2DB22D9353
    Indefinite Delivery Contract
  • SPE2DB22D9353-SPE2DB25FX1SS
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of EYLEA HD 8 MG/0.07 ML VIAL 0.07ML, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract has a ceiling value of $5,943.78 and is a firm fixed-price delivery order with a performance period extending through March 19, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 5/28/25, 10:57 AM